QURE Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $23.46
Market Cap (MRQ) $1.63B
P/E (TTM) -5.8
EPS (TTM) $-4.02
Revenue (TTM) $19M
ROE (TTM) -157.6%
Debt/Equity (MRQ) 0.2
52W Range $9–$72

QURE Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$16M
2016-12-31 → 2025-12-31
EPS$-3.46
2019-12-31 → 2025-12-31
Free Cash Flow$-178M
2016-12-31 → 2025-12-31
Net margin-1350.7%
2017-12-31 → 2025-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend QURE 5Y avg Peer Median Verdict
P/E (TTM) -5.85Y avg ≈-3.4 ≈-3.4 · ·
P/S (TTM) 87.15Y avg ≈31.4 ≈31.4 · ·
P/B (MRQ) 5.05Y avg ≈-23.0 ≈-23.0 · ·
EV / EBITDA -7.85Y avg ≈-3.5 ≈-3.5 · ·
Price / FCF (TTM) -10.15Y avg ≈-3.6 ≈-3.6 · ·
Price / Cash Flow (TTM) -10.15Y avg ≈-3.9 ≈-3.9 · ·
EV / Revenue 90.05Y avg ≈28.0 ≈28.0 · ·
EV / FCF -8.15Y avg ≈-3.5 ≈-3.5 · ·
Price / Tangible Book (MRQ) 6.25Y avg ≈5.5 ≈5.5 · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise -2.1%
Next Report Nov 09, 2026
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 $-1.22 $-0.84 -45.1%
March 31, 2026 May 12, 2026 $-0.85 $-0.89 4.9%
Dec. 31, 2025 $-0.64 $-0.97 33.7%
Sept. 30, 2025 $-1.38 $-0.92 -50.4%
June 30, 2025 $-0.69 $-0.91 24.4%
March 31, 2025 $-0.82 $-1.03 20.0%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 17
Metric Trend 20252024202320222021202020192018201720162015
Revenue $16M$27M$16M$106M$524M$38M$7M$11M$13M$25M$11M
Cost of Revenue $2M$1M$65.0K$1M$25M$3M$2M$1M$817.0K$1M·
R&D Expense $141M$144M$215M$198M$144M$122M$95M$75M$72M$73M$59M
SG&A Expense $65M$53M$75M$55M$56M$43M$34M$25M$25M$26M$23M
Operating Expenses $208M$215M$303M$256M$225M$165M$128M$100M$97M$99M$83M
Operating Income $-185M$-184M$-283M$-143M$311M$-125M$-121M$-88M$-71M$-72M$-71M
Interest Expense ··$42M$12M$7M$4M$4M$2M$2M$2M$3M
Interest Income $17M$21M$20M$609.0K$162.0K$938.0K$4M$3M$117.0K$70.0K$121.0K
Other Non-op $11M··$3M$-160.0K$483.0K$-3M$208.0K$-2M$785.0K$-7M
Pretax Income $-193M$-237M$-307M$-128M$333M$-141M$-124M$-83M$-79M$-72M$-83M
Income Tax $6M$2M$2M$-1M$3M$-16M·$231.0K$-199.0K$1M$-1M
Net Income $-199M$-240M$-308M$-127M$330M$-125M$-124M$-83M$-79M$-73M$-82M
EPS (Basic) $-3.46$-4.92$-6.47$-2.71$7.17$-2.81$-3.11····
EPS (Diluted) $-3.46$-4.92$-6.47$-2.71$7.04$-2.81$-3.11····
Shares (Basic) 57,502,06848,649,12947,670,98646,735,04545,986,46744,466,36539,999,450····
Shares (Diluted) 57,502,06848,649,12947,670,98646,735,04546,840,97244,466,36539,999,450····
EBITDA $-185M$-184M$-283M$-143M$311M$-125M$-121M·$-71M$-72M·
Balance Sheet 29
Metric Trend 20252024202320222021202020192018201720162015
Cash & Equivalents $80M$159M$241M$228M$556M$245M$378M$235M$159M$132M$222M
Receivables $6M····$7M···$4M·
Inventory ··$12M$7M······$474.0K
Prepaid Expense $21M$9M$15M$12M$11M$4M$5M$1M$1M$996.0K$690.0K
Other Current Assets ·····$3M$748.0K$329.0K$687.0K$1M$1M
Current Assets $656M$390M$652M$477M$628M$259M$384M$237M$163M$144M$228M
PP&E (Net) $14M$20M$47M$51M$44M$32M$29M$29M$34M$36M$26M
PP&E (Gross) $58M$52M$102M$95M$80M$68M$57M$52M$51M$48M$37M
Accum. Depreciation $44M$32M$56M$44M$37M$35M$29M$23M$17M$12M$11M
Goodwill $25M$22M$26M$26M$28M$542.0K$496.0K$506.0K$530.0K$465.0K$481.0K
Intangibles $73M$71M$60M$59M$63M$3M$5M$5M$10M$8M$7M
Other Non-current Assets $6M$1M$3M$6M$6M$3M··$2M$2M$1M
Total Assets $825M$557M$832M$705M$809M$340M$449M$274M$210M$190M$263M
Accounts Payable $5M$7M$7M$11M$3M$4M$6M$4M$3M$6M$4M
Accrued Liabilities $41M$29M$31M$31M$28M$18M$12M$8M···
Current Liabilities $63M$40M$74M$76M$37M$27M$32M$20M$19M$23M$27M
Capital Leases $10M$11M$28M$32M$29M$30M$31M····
Deferred Tax $8M$7M$8M$8M$13M······
Other Non-current Liabilities $4M$8M$4M$935.0K$4M$3M$534.0K$435.0K$614.0K$51.0K$578.0K
Total Liabilities $626M$563M$624M$229M$213M$96M$126M$94M$120M$127M$135M
Long-term Debt $72M$66M$148M$144M$136M$42M$47M$48M$24M$20M$20M
Total Debt $50M$51M$102M$103M$101M$36M$36M·$21M$20M·
Common Stock $4M$3M$3M$3M$3M$3M$3M$2M$2M$2M$2M
Paid-in Capital $1.58B$1.17B$1.15B$1.11B$1.08B$1.02B$987M$720M$567M$465M$456M
Retained Earnings $-1.33B$-1.13B$-890M$-582M$-455M$-785M$-660M$-536M$-475M$-396M$-323M
AOCI $-58M$-53M$-54M$-58M$-29M$-10M$-7M$-7M$-4M$-7M$-7M
Stockholders' Equity $199M$-7M$208M$476M$596M$244M$323M$180M$89M$64M$128M
Liabilities + Equity $825M$557M$832M$705M$809M$340M$449M$274M$210M$190M$263M
Shares Outstanding 62,336,71748,988,08747,833,83046,968,03246,298,63544,777,79943,711,95437,351,65331,339,04025,257,42024,327,944
Cash Flow 16
Metric Trend 20252024202320222021202020192018201720162015
D&A $15M$13M$12M$9M$7M$11M$7M$12M$8M··
Stock-based Comp $18M$22M$35M$34M$26M$22M$18M$11M$10M$6M$12M
Deferred Tax $2M$2M$2M$-1M$3M$-16M·$209.0K$-209.0K$1M$-1M
Restructuring ··$3M········
Operating Cash Flow $-178M$-183M$-146M$-145M$288M$-135M$-99M$-76M$-64M$-72M$7M
CapEx $439.0K$3M$7M$18M$17M$7M$6M$2M$4M$15M$8M
Investing Cash Flow $-322M$163M$-206M$-183M$-67M$-9M$-7M$-4M$-6M$-17M$-8M
Debt Issued ····$64M··$15M···
Net Debt Issued ·$-53M··$64M······
Stock Issued ····$31M$7M$6M$5M$4M$3M$3M
Net Stock Activity ····$3M$7M$6M·$4M$3M·
Financing Cash Flow $415M$-59M$363M$1M$95M$7M$249M$158M$90M$2M$161M
Net Change in Cash $-79M$-84M$13M$-328M$312M$-133M$143M$75M$28M$-89M$157M
Taxes Paid $8M$21.0K$12.0K········
Free Cash Flow $-178M$-186M$-153M$-163M$271M$-142M$-104M·$-69M$-87M·
Levered FCF ··$-195M$-174M$263M$-145M··$-71M$-90M·
Profitability 7
Metric Trend 20252024202320222021202020192018201720162015
Operating Margin -1151.4%-679.6%-1785.5%-134.4%59.3%-334.3%-1663.8%·-544.3%-286.7%·
Net Margin -1236.0%-883.4%-1947.1%-119.1%62.9%-333.3%-1705.8%·-604.7%··
Pretax Margin -1201.0%-874.4%-1935.0%-120.4%63.5%-377.0%-1705.8%·-606.2%-287.8%·
EBITDA Margin -1151.4%-679.6%-1785.5%-134.4%59.3%-334.3%-1663.8%·-544.3%-286.7%·
ROA -28.8%-34.5%-40.2%-16.8%57.3%-31.7%-34.4%·-39.6%··
ROE -204.2%-976.4%-129.5%-28.3%55.6%-53.0%-36.9%·-103.6%··
ROIC -76.7%-417.7%-92.0%-24.4%44.1%-39.7%··-64.6%-87.2%·
Liquidity & Solvency 5
Metric Trend 20252024202320222021202020192018201720162015
Current Ratio 10.49.78.86.317.19.512.1·8.56.3·
Quick Ratio 1.34.03.33.015.19.211.9·8.36.0·
Debt / Equity 0.2-7.60.50.20.20.10.1·0.20.3·
LT Debt / Equity 0.2-7.60.50.20.20.10.1·0.20.3·
Interest Coverage ··-6.8-12.241.6-32.8-31.8·-32.0-33.1·
Efficiency 3
Metric Trend 20252024202320222021202020192018201720162015
Asset Turnover 0.00.00.00.10.90.10.0·0.10.1·
Inventory Turnover ··0.00.3·······
Receivables Turnover ·····7.3···13.6·
Per Share 5
Metric Trend 20252024202320222021202020192018201720162015
Book Value / Share $3.19$-0.14$4.34$10.13$12.87$5.45$7.39·$2.85$2.52·
Revenue / Share $0.28$0.56$0.33$2.28$11.19······
Cash Flow / Share $-3.09$-3.76$-3.06$-3.10$6.15······
Cash / Share $1.29$3.24$5.05$4.85$12.01$5.47$8.64·$5.09$5.25·
EPS (TTM) $-3.46$-4.92$-6.47$-2.71$7.04$-2.81$-3.11····
Growth Rates 3
Metric Trend 20252024202320222021202020192018201720162015
Revenue YoY -40.6%71.2%-85.1%-79.7%1296.8%······
Revenue CAGR 3Y -46.7%-62.7%-25.0%········
Revenue CAGR 5Y -15.6%··········
Valuation (TTM) 14
Metric Trend 20252024202320222021202020192018201720162015
Revenue TTM $16M$27M$16M$106M$524M$38M$7M$11M$13M$25M·
Net Income TTM $-199M$-240M$-308M$-127M$330M$-125M$-124M$-83M$-79M$-73M·
Market Cap $1.49B$865M$324M$1.06B$960M$1.62B$3.13B·$614M$141M·
Enterprise Value $1.46B$758M$184M$940M$505M$1.41B$2.79B·$475M$29M·
P/E -6.9-3.6-1.0-8.42.9-12.9-23.0····
P/S 92.731.920.410.01.843.1430.2·46.85.6·
P/B 7.5-128.11.62.21.66.69.7·6.92.2·
P / Tangible Book 14.8·2.72.71.96.7·····
P / Cash Flow -8.4-4.7-2.2-7.33.3-12.0-31.7·-9.6-2.0·
P / FCF -8.4-4.6-2.1-6.53.5-11.4-30.0·-8.9-1.6·
EV / EBITDA -7.9-4.1-0.7-6.61.6-11.2-23.0·-6.7-0.4·
EV / FCF -8.2-4.1-1.2-5.81.9-9.9-26.7·-6.9-0.3·
EV / Revenue 90.827.911.68.81.037.5383.3·36.31.2·
Earnings Yield -14.5%-27.9%-95.6%-11.9%33.9%-7.8%-4.3%····

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $16M $27M $16M $106M $524M
Operating Margin % -1151.4% -679.6% -1785.5% -134.4% 59.3%
Net Income $-199M $-240M $-308M $-127M $330M
Diluted EPS $-3.46 $-4.92 $-6.47 $-2.71 $7.04

Institutional owners (13F) 312 filers · $3.6B total · As of Sept. 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 312
Value held $3.6B
New positions 98
Exited positions 45
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
98 (+36 vs prior Q) 45 (-3 vs prior Q) 97 (+9 vs prior Q) 80 (+6 vs prior Q) +1.2M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
Avoro Capital Advisors LLC $309,881,409 6,727,777 8.58% Shares
JPMORGAN CHASE & CO $230,813,250 4,867,755 6.39% Shares
RTW INVESTMENTS, LP $181,548,806 3,941,572 5.02% Shares
STATE STREET CORP $133,750,180 2,903,825 3.70% Shares
Aberdeen Group plc $131,184,269 2,848,117 3.63% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $118,728,862 2,577,700 3.29% Call option
BlackRock, Inc. $86,475,484 1,877,453 2.39% Shares
ORBIMED ADVISORS LLC $83,252,805 1,807,486 2.30% Shares
Caption Management, LLC $74,967,256 1,627,600 2.07% Call option
JANE STREET GROUP, LLC $74,178,847 1,610,483 2.05% Shares
JENNISON ASSOCIATES LLC $71,918,636 1,561,412 1.99% Shares
Boxer Capital Management, LLC $69,241,998 1,503,300 1.92% Shares
GOLDMAN SACHS GROUP INC $67,982,533 1,475,956 1.88% Shares
TWO SIGMA INVESTMENTS, LP $67,340,825 1,462,024 1.86% Shares
Two Seas Capital LP $66,391,345 1,441,410 1.84% Shares
FMR LLC $58,499,338 1,270,068 1.62% Shares
MAK CAPITAL ONE LLC $56,748,269 1,232,051 1.57% Shares
MPM BIOIMPACT LLC $56,462,881 1,225,855 1.56% Shares
MORGAN STANLEY $49,129,407 1,066,639 1.36% Shares
CITADEL ADVISORS LLC $46,069,212 1,000,200 1.27% Call option
Vestal Point Capital, LP $43,066,100 935,000 1.19% Shares
MAVERICK CAPITAL LTD $42,623,141 925,383 1.18% Shares
CITADEL ADVISORS LLC $41,930,168 910,338 1.16% Shares
Fiera Capital Corp $41,875,034 909,141 1.16% Shares
Integral Health Asset Management, LLC $41,454,000 900,000 1.15% Shares
GEODE CAPITAL MANAGEMENT, LLC $39,658,136 860,631 1.10% Shares
Longaeva Partners L.P. $37,059,600 804,594 1.03% Shares
Nantahala Capital Management, LLC $36,848,000 800,000 1.02% Call option
VANGUARD CAPITAL MANAGEMENT LLC $35,916,621 779,779 0.99% Shares
CITIGROUP INC $30,629,900 665,000 0.85% Call option
Invesco Ltd. $28,917,526 627,823 0.80% Shares
First Turn Management, LLC $28,047,086 608,925 0.78% Shares
Point72 Asset Management, L.P. $27,922,125 606,212 0.77% Shares
CITADEL ADVISORS LLC $27,484,002 596,700 0.76% Put option
Balyasny Asset Management L.P. $27,017,967 586,582 0.75% Shares
Kinetic Partners Management, LP $26,760,860 581,000 0.74% Shares
BANK OF AMERICA CORP /DE/ $26,658,884 578,786 0.74% Shares
TWO SIGMA ADVISERS, LP $26,571,872 1,110,400 0.74% Shares
683 Capital Management, LLC $26,484,501 575,000 0.73% Shares
TUDOR INVESTMENT CORP ET AL $25,254,698 548,300 0.70% Call option
JANE STREET GROUP, LLC $25,231,668 547,800 0.70% Call option
VANGUARD GROUP INC $25,159,500 1,051,379 0.70% Shares
GILDER GAGNON HOWE & CO LLC $24,456,893 530,979 0.68% Shares
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. $24,028,443 521,677 0.66% Shares
Assenagon Asset Management S.A. $23,653,192 513,530 0.65% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $22,887,076 496,897 0.63% Shares
UBS Group AG $21,536,321 467,571 0.60% Shares
Nantahala Capital Management, LLC $20,987,700 455,660 0.58% Shares
Voss Capital, LP $20,743,628 450,361 0.57% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $19,349,806 420,100 0.54% Put option

Show all 312 institutional owners →

Activists & 5%+ owners 1 position

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Coller Investment Management Limited, Coller International General Partner V, L.P, Coller International Partners V-A, L.P ×4 filings April 3, 2019 · Initial filing · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 28 insiders · 17 officers · 12 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Matthew C Kapusta CEO, Managing Director July 2, 2026 M 519,227 0 16 $-12,864,927
Christian Klemt Chief Financial Officer March 4, 2026 A 226,581 0 3 $-381,751
Ricardo Dolmetsch President, R&D Sept. 18, 2023 S 163,404 0 0 $0
Pierre Caloz Chief Operating Officer June 17, 2024 S 115,707 0 0 $0
Scott T. Mcmillan Chief Operating Officer Jan. 28, 2019 S 20,432 0 0 $0
Walid Abi-Saab Chief Medical Officer June 30, 2026 M 148,235 0 7 $-2,611,134
Jeannette Potts Chief Legal Officer June 15, 2026 S 133,246 0 3 $-261,172
Kylie O'Keefe Chief Customer & Strat Officer June 11, 2026 S 108,864 0 1 $-431,228
Alexander Edward Kuta III Executive VP, Operations March 7, 2023 S 90,381 0 0 $0
Sander Van Deventer EVP, Research & Product Dev. Feb. 27, 2020 A 61,599 0 0 $0
Steven Zelenkofske Chief Medical Officer June 6, 2018 S 159,458 0 0 $0
Jonathan Garen Chief Business Officer Jan. 26, 2018 A 93,638 0 0 $0
Paul E Firuta Chief Commercial Officer Jan. 26, 2018 A 93,817 0 0 $0
Maria E Cantor SVP, Investor Rel. & Comm. Jan. 26, 2018 A 92,439 0 0 $0
Harald Petry Chief Scientific Officer June 29, 2017 M 0 0 0 $0
Christian Meyer Chief Medical Officer Jan. 27, 2017 A · 0 0 $0
Maiken Keson-Brookes General Counsel Jan. 27, 2017 A · 0 0 $0
Jack Kaye Director June 30, 2026 M 25,996 0 9 $-2,693,581
Madhavan Balachandran Director June 17, 2026 M 43,254 0 5 $-858,916
Rachelle Suzanne Jacques Director June 10, 2026 A 33,903 0 1 $-53,931
Jeremy P. Springhorn Director June 10, 2026 A 43,251 0 1 $-53,931
Robert Gut Director June 10, 2026 A 32,259 0 9 $-1,757,850
David D. Meek Director June 10, 2026 A 39,747 0 1 $-53,931
Leonard E Post Director June 10, 2026 A 35,494 0 1 $-53,931
Paula Soteropoulos Director June 13, 2024 S 20,203 0 0 $0
Philip Astley-Sparke Director March 2, 2021 S 9,946 0 0 $0
David Schaffer Director Feb. 27, 2020 A 46,978 0 0 $0
William Lewis Director Jan. 27, 2017 A · 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 12 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
PTH · Invesco Exchange-Traded Fund Trust 0.79% 120,827 SH Oct. 1, 2026 Daily
LABU · Direxion Shares ETF Trust 0.72% 81,217 NS July 31, 2026 N-PORT
DWAS · Invesco Exchange-Traded Fund Trust … 0.27% 45,339 SH Oct. 1, 2026 Daily
IBB · iShares Trust 0.21% 492,076 SH Sept. 11, 2026 Daily
IBBQ · Invesco Exchange-Traded Fund Trust … 0.11% 4,906 SH Oct. 1, 2026 Daily
ESML · iShares Trust 0.05% 30,024 SH Sept. 11, 2026 Daily
VXF · VANGUARD INDEX FUNDS 0.03% 757,841 SH Aug. 19, 2026 Daily
VHT · VANGUARD WORLD FUND 0.03% 141,093 SH Aug. 19, 2026 Daily
WSML · iShares Trust 0.02% 2,657 SH Sept. 11, 2026 Daily
ITOT · iShares Trust 0.00% 89,136 SH Sept. 11, 2026 Daily
ISCB · iShares Trust · 2,897 SH Sept. 11, 2026 Daily
ISCV · iShares Trust · 14,325 SH Sept. 11, 2026 Daily

QURE Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 20 analysts BUY
Median target $69.54 +196.4%
7 35.0% Strong Buy
11 55.0% Buy
2 10.0% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

11 analysts · 2026-10-03

Mean target $65.48 +179.1%

← Below all targets Current price $23.46
Low$30.80 Mean$65.48 High$91.95

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
QURE $1.49B -6.9 -40.6% -1236.0% -204.2% ·
NAMS · · · · · ·
PRQR · -5.0 · · -61.2% ·

Latest News Recent headlines mentioning this company

23

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Jul 29, 2026